Drugs / Hypertonic saline solutions
last change Apr 2016 re-read 2 minutes ago

Hypertonic saline solutions

also known as HSS
Developed for
cirrhosis of liver
Investigated by
University of Palermo

Trials 1 · a red edge is where a trial was stopped

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02821377 Dec 2013 → Dec 2015 cirrhosis of liver University of Palermo Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Hypertonic saline solutions ClinicalTrials.gov intervention name — accepted as the source's own label NCT02821377
Known as HSS “Intravenous small volumes of HSS (150mL 1.4-4.6% NaCl), plus treatment with intravenous infusion of furosemide (doses 125-250mg⁄ bid) from the first day after admission until 3...” NCT02821377
Route Intravenous Intravenous small volumes of HSS” NCT02821377